Wordt geladen...
CD57(+) CD4 T cells underlie belatacept-resistant allograft rejection
Belatacept is a B7-specific fusion protein used to prevent allograft rejection by blocking T cell costimulation. Generally efficacious, it fails to prevent acute rejection in a sizable minority of patients. In experimental models, memory T cells mediate costimulation blockade-resistant rejection (Co...
Bewaard in:
| Gepubliceerd in: | Am J Transplant |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4867077/ https://ncbi.nlm.nih.gov/pubmed/26603381 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ajt.13613 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|